Skip to content

Quality of Neuropsychological Assessment: Effect of Feedback on Neuropsychological Performance and Treatment-outcome

Quality of Neuropsychological Assessment: Effect of Feedback on Neuropsychological Performance and Treatment-outcome - Quality of Neuropsychological Assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47362
Enrollment
512
Registered
2015-12-23
Start date
2016-02-17
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

underperformance

Interventions

In case the patient passed the ASTM, the following feedback is provided: No feedback on performance (FB-). Verbatim, in Dutch: * In het kader van het onderzoek zal ik enkele testen die ik zojuist bij

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients clinically referred for, and cognitively capable of undergoing full neuropsychological assessment - * 18 years old - Mental competency to give informed consent - Dutch proficiency - A minimum of 8 years of formal schooling and no history of mental retardation

Exclusion criteria

Exclusion criteria: Severe and obvious cognitive problems (see p. 12 of the study protocol)

Design outcomes

Secondary

MeasureTime frame
Secondly, we want to investigate to what extent SVT failure and external gain expectations in this sample predicts treatment-outcome according to self-reported health status (i.e., SF-36) and medical consumption (i.e., iMCQ) three months after the neuropsychological assessment.

Primary

MeasureTime frame
The percentage of patients that score better on a repeated SVT (i.e., ASTM) and subsequent neuropsychological testing (i.e., VLT and SCWT) after providing feedback on SVT failure (FB+), compared to the percentage of patients that show improvement on these tests that were not given this feedback (FB-).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)